Abstract:Inspired by multivalent interactions between antibodies and antigens, a strategy using a preorganized DNA‐triangle framework library is developed to implement de novo evolution of an "Antibody‐mimicking multivalent aptamer" (Amap) for epithelial cell adhesion molecule (EpCAM) through systematic evolution of ligands by exponential enrichment (SELEX) technology (denoted as Amap‐SELEX), which could potentially become a common method for multivalent aptamer selection. Multivalent interactions can often endow ligands with more efficient binding performance toward target molecules. Generally speaking, a multivalent aptamer can be constructed via post‐assembly based on chemical structural information of target molecules and pre‐identified monovalent aptamers derived from traditional systematic evolution of ligands by exponential enrichment (SELEX) technology. However, many target molecules may not have known matched aptamer partners, thus a de novo evolution will be highly desired as an alternative strategy for directed selection of a high‐avidity, multivalent aptamer. Here, inspired by the superiority of multivalent interactions between antibodies and antigens, a direct SELEX strategy with a preorganized DNA framework library for an "Antibody‐mimicking multivalent aptamer" (Amap) selection to epithelial cell adhesion molecule (EpCAM), a model target protein is reported. The Amap presents a relatively good binding affinity through both aptamer moieties concurrently binding to EpCAM, which has been confirmed by affinity analysis and molecular modeling. Furthermore, dynamic interactions between Amap and EpCAM are directly visualized by magnetic tweezers at the single‐molecule level. A nice binding affinity of Amap to EpCAM‐positive cancer cells has also been verified, which hints that their Amap‐SELEX strategy has the potential to be a new route for de novo evolution of multivalent aptamers.

Identification of DNA Aptamers toward Epithelial Cell Adhesion Molecule via Cell-SELEX

Selection of DNA Aptamers Against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture.

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

Characterization of Epithelial Cell Adhesion Molecule as a Surface Marker on Undifferentiated Human Embryonic Stem Cells

Selection of DNA Aptamers Against Epidermal Growth Factor Receptor with High Affinity and Specificity.

Selection of aptamers for molecular recognition and characterization of cancer cells.

SELEX screening of EpCAMGspecific nucleic acid aptamer targeting prostate cancer cells

Aptamers Generated by Cell SELEX for Biomarker Discovery

Sensitive Electrochemical Aptasensor for Detecting EpCAM with Silica Nanoparticles and Quantum Dots for Signal Amplification

Double hook-type aptamer-based colorimetric and electrochemical biosensor enables rapid and robust analysis of EpCAM expression

Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells

Dna Aptamer As Molecular Recognition Probe To Selectively Differentiate Tumor Cells

Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples

De Novo Evolution of an Antibody‐Mimicking Multivalent Aptamer via a DNA Framework

The application progress in cell-SELEX-based aptamers in cancer

Evolution of Nucleic Acid Aptamers Capable of Specifically Targeting Glioma Stem Cells via Cell-SELEX.

Development of DNA Aptamers to Native EpCAM for Isolation of Lung Circulating Tumor Cells from Human Blood

Anti-epithelial Cell Adhesion Molecule Monoclonal Antibody Conjugated Fluorescent Nanoparticle Biosensor for Sensitive Detection of Colon Cancer Cells

Aptamers Selected By Cell-Selex For Application In Cancer Studies

Selection and Characterization of Novel DNA Aptamer Against Colorectal Carcinoma Caco-2 Cells